Effects of intermittent fasting regimens on glycemic, hepatic, anthropometric, and clinical markers in patients with non-alcoholic fatty liver disease: Systematic review and meta-analysis of randomized controlled trials.
Clin Nutr ESPEN
; 59: 70-80, 2024 02.
Article
en En
| MEDLINE
| ID: mdl-38220409
ABSTRACT
OBJECTIVES:
Intermittent fasting (IF) regimens have been hypothesized to influence several markers of cardiometabolic and liver function. The objective of our meta-analysis was to investigate the impact of IF regimens on cardiometabolic and liver markers in subjects diagnosed with non-alcoholic fatty liver disease (NAFLD).METHODS:
We searched several online databases (PubMed/Medline, Web of Science, Scopus and Embase) in order to identify suitable publications for inclusion in the meta-analysis. Results were expressed as weighted mean differences (WMD).RESULTS:
From 12343 articles identified in different databases, a total of 7 RCT arms were entered into the quantitative synthesis. The manuscripts were published between 2019 and 2023. IF regimens (the 52 diet, 16/8 time-restricting feeding, and alternate day fasting) varied from 2 months to 3 months. IF regimens reduced steatosis scores (WMD -33.22 CAP dB/m, 95 % CI -50.72 to -15.72), anthropometric characteristics of obesity (WMD -0.77 kg/m2, 95 % CI -1.38 to -0.17 for body mass index; WMD -3.16 kg, 95 % CI -4.71 to -1.61 for body weight; WMD -1.90 kg, 95 % CI -3.51 to -0.29 for waist circumference), as well as ALT (WMD -9.10 U/L, 95 % CI -12.45 to -5.75), triglyceride (WMD -20.83 mg/dl, 95 % CI -39.01 to -2.66), total cholesterol (WMD -7.80 mg/dl, 95 % CI -15.18), HbA1c (WMD -0.14 %, 95 % CI -0.20 to -0.08) and HOMA-IR (WMD -1.21, 95 % CI -2.08 to -0.34) levels versus controls. Nevertheless, no between-group differences were detected for other biomarkers, e.g., fasting blood glucose, insulin, AST, HDL-C or LDL-C values, and fibrosis scores.CONCLUSION:
IF regimens can improve some markers of cardiometabolic and liver function in patients with NAFLD. However, the available evidence to support the benefits of IF regimens is limited and derived from a small number of studies, thus further research is needed to clarify the impact of IF on the cardiometabolic health of NAFLD patients.Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Enfermedades Cardiovasculares
/
Enfermedad del Hígado Graso no Alcohólico
Tipo de estudio:
Clinical_trials
/
Prognostic_studies
/
Systematic_reviews
Límite:
Humans
Idioma:
En
Revista:
Clin Nutr ESPEN
Año:
2024
Tipo del documento:
Article
País de afiliación:
Egipto
Pais de publicación:
Reino Unido